Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

The Prognosis in Palliative care Study II (PiPS2): study protocol for a multi-centre, prospective, observational, cohort study.

Kalpakidou AK, Todd C, Keeley V, Griffiths J, Spencer K, Vickerstaff V, Omar RZ, Stone P.

BMC Palliat Care. 2018 Aug 13;17(1):101. doi: 10.1186/s12904-018-0352-y.

2.

Advances in understanding and management of lymphoedema (cancer, primary).

Keeley V.

Curr Opin Support Palliat Care. 2017 Dec;11(4):355-360. doi: 10.1097/SPC.0000000000000311. Review.

PMID:
28984676
3.

Non-adherence to treatment of chronic wounds: patient versus professional perspectives.

Moffatt C, Murray S, Keeley V, Aubeeluck A.

Int Wound J. 2017 Dec;14(6):1305-1312. doi: 10.1111/iwj.12804. Epub 2017 Aug 30.

PMID:
28857457
4.

Identifying priority areas for research into the diagnosis, treatment and prevention of cellulitis (erysipelas): results of a James Lind Alliance Priority Setting Partnership.

Thomas KS, Brindle R, Chalmers JR, Gamble B, Francis NA, Hardy D, Hooper J, Keeley V, Levell NJ, McPhee M, Metcalf L, Santer M, Tarpey M, Smart P, Wallace A, Wilkes S.

Br J Dermatol. 2017 Aug;177(2):541-543. doi: 10.1111/bjd.15634. Epub 2017 Jun 14. No abstract available.

PMID:
28477399
5.

Future Research Priorities for Morbidity Control of Lymphedema.

Narahari SR, Aggithaya MG, Moffatt C, Ryan TJ, Keeley V, Vijaya B, Rajendran P, Karalam SB, Rajagopala S, Kumar NK, Bose KS, Sushma KV.

Indian J Dermatol. 2017 Jan-Feb;62(1):33-40. doi: 10.4103/0019-5154.198039.

6.

Chronic oedema: a prevalent health care problem for UK health services.

Moffatt CJ, Keeley V, Franks PJ, Rich A, Pinnington LL.

Int Wound J. 2017 Oct;14(5):772-781. doi: 10.1111/iwj.12694. Epub 2016 Dec 4.

PMID:
27917617
7.

Development of Prognosis in Palliative care Study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study.

Gwilliam B, Keeley V, Todd C, Gittins M, Roberts C, Kelly L, Barclay S, Stone PC.

BMJ Support Palliat Care. 2015 Dec;5(4):390-8. doi: 10.1136/bmjspcare-2012-d4020rep.

PMID:
26586684
8.

Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer.

Bundred NJ, Stockton C, Keeley V, Riches K, Ashcroft L, Evans A, Skene A, Purushotham A, Bramley M, Hodgkiss T; Investigators of BEA/PLACE studies.

Breast Cancer Res Treat. 2015 May;151(1):121-9. doi: 10.1007/s10549-015-3357-8. Epub 2015 Apr 8.

PMID:
25850535
9.

The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review.

Atton G, Gordon K, Brice G, Keeley V, Riches K, Ostergaard P, Mortimer P, Mansour S.

Eur J Hum Genet. 2015 Dec;23(12):1634-9. doi: 10.1038/ejhg.2015.41. Epub 2015 Mar 25. Review.

10.

Factors affecting recruitment to an observational multicentre palliative care study.

Stone PC, Gwilliam B, Keeley V, Todd C, Kelly LC, Barclay S.

BMJ Support Palliat Care. 2013 Sep;3(3):318-23. doi: 10.1136/bmjspcare-2012-000396. Epub 2013 Jan 7.

11.

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.

Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams.

Vaccine. 2013 Oct 1;31(42):4782-90. doi: 10.1016/j.vaccine.2013.08.002. Epub 2013 Aug 14.

12.

Penicillin to prevent recurrent leg cellulitis.

Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, Nasr IS, Brindle RJ, English J, Meredith SK, Reynolds NJ, de Berker D, Mortimer PS, Williams HC; U.K. Dermatology Clinical Trials Network's PATCH I Trial Team.

N Engl J Med. 2013 May 2;368(18):1695-703. doi: 10.1056/NEJMoa1206300.

13.

The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings.

Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer PS, Mansour S, Ostergaard P.

Clin Genet. 2013 Oct;84(4):303-14. doi: 10.1111/cge.12173. Epub 2013 Jun 27. Review.

PMID:
23621851
14.

Prognosticating in patients with advanced cancer--observational study comparing the accuracy of clinicians' and patients' estimates of survival.

Gwilliam B, Keeley V, Todd C, Roberts C, Gittins M, Kelly L, Barclay S, Stone P.

Ann Oncol. 2013 Feb;24(2):482-8. doi: 10.1093/annonc/mds341. Epub 2012 Oct 1.

PMID:
23028038
15.

Patients' reports or clinicians' assessments: which are better for prognosticating?

Stone P, Gwilliam B, Keeley V, Todd C, Gittins M, Kelly L, Barclay S, Roberts C.

BMJ Support Palliat Care. 2012 Sep;2(3):219-23. doi: 10.1136/bmjspcare-2012-000216. Epub 2012 Jun 1.

PMID:
24654194
16.

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Qin M, Levin MJ, Fenton T, Beeler JA, Bellini WJ, Audet S, Sowers SB, Borkowsky W, Nachman SA, Pelton SI, Rosenblatt HM; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams.

J Infect Dis. 2012 Aug 15;206(4):512-22. doi: 10.1093/infdis/jis386. Epub 2012 Jun 12.

17.

Development of Prognosis in Palliative care Study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study.

Gwilliam B, Keeley V, Todd C, Gittins M, Roberts C, Kelly L, Barclay S, Stone PC.

BMJ Support Palliat Care. 2012 Mar;2(1):63-71. doi: 10.1136/bmjspcare.2012.d4920rep.

PMID:
24653502
18.

Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial.

UK Dermatology Clinical Trials Network’s PATCH Trial Team, Thomas K, Crook A, Foster K, Mason J, Chalmers J, Bourke J, Ferguson A, Level N, Nunn A, Williams H.

Br J Dermatol. 2012 Jan;166(1):169-78. doi: 10.1111/j.1365-2133.2011.10586.x. Epub 2011 Dec 6.

19.

Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study.

Gwilliam B, Keeley V, Todd C, Gittins M, Roberts C, Kelly L, Barclay S, Stone PC.

BMJ. 2011 Aug 25;343:d4920. doi: 10.1136/bmj.d4920.

20.

A new classification system for primary lymphatic dysplasias based on phenotype.

Connell F, Brice G, Jeffery S, Keeley V, Mortimer P, Mansour S.

Clin Genet. 2010 May;77(5):438-52. doi: 10.1111/j.1399-0004.2010.01394.x.

PMID:
20447153

Supplemental Content

Loading ...
Support Center